Thymosin Alpha-1
Strong recommend, BioHarmony verdict
BioHarmony score 7.4 out of 10
Thymosin Alpha-1 is a 28-amino-acid thymic peptide with strongest evidence in immune-compromised and hospital-adjacent settings: Cao 2024 pooled 39 acute COPD exacerbation RCTs, while TESTS 2025 found no clear 28-day sepsis mortality benefit.
Read full reportWhat is Thymosin Alpha-1?
Thymosin Alpha-1, also called thymalfasin or TA-1, is a 28-amino-acid thymic peptide used internationally as Zadaxin and in the United States through non-FDA-approved peptide channels. Its core role is immune modulation: TA-1 helps dendritic cells bridge innate and adaptive immunity, nudges T-helper signaling toward antiviral Th1 activity, supports CD4/CD8 recovery in lymphopenic states, and may improve monocyte HLA-DR expression in sepsis-induced immune suppression.
From the BioHarmony report, reviewed Sep 8, 2026.
Saved on this device only.
How it is thought to work
TLR9 and TLR2 signaling on dendritic cells, NF-kB activation, Th1 polarization, CD4/CD8 normalization, NK-cell support, and IDO-mediated immune tolerance.
Safety watch-outs
- Injection-site infection
- Autoimmune flare symptoms
Full risk profile in the BioHarmony report.
Dosing as published
Source-reported figures only. This page does not calculate a personal dose.
No approved-label or study protocol is recorded for Thymosin Alpha-1 yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (4)
Attributed viewpoints, separate from primary research.
- International Peptide Society 2018 Compound Curriculum Dr. William Seeds,
- Peptides to Promote Cellular Health Dr. Suzanne Ferree,
- Thymosin Alpha-1: 2025 Update on My Favorite Immune Peptide Hunter Williams,
- Thymosin Alpha 1 vs Thymosin Beta 4: Key Differences Jay Campbell,
Trust & sourcing
- Last revieweddone
- Next reviewupcoming
FDA identifies immunogenicity and peptide-impurity concerns for compounded thymosin alpha-1 and says available safety information is inadequate.
Primary sources
- Certain bulk drug substances for use in compounding that may present significant safety risks U.S. Food and Drug Administration,
Related peptides for recovery & tissue repair
- 7.2GHK-Cu (Copper Peptide)GHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
- 7.1SemaxSemax is a Russian-developed ACTH 4-7 + PGP heptapeptide with the strongest human signal in post-stroke recovery, including a 110-patient Gusev et al.
- 6.9Thymosin Beta-4 (Full)Thymosin beta-4 is the native 43-amino-acid peptide that promotes tissue repair via actin-sequestering and the Ac-SDKP repair axis.
- 6.7ARA-290ARA-290 (cibinetide) is an EPO-derived peptide that activates the innate repair receptor to regrow small nerve fibers without EPO's blood effects.
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.